Summary of Guideline for the Treatment of Bipolar Disorder

The past decade has witnessed an extraordinary expansion of treatments available for bipolar disorder. Ten years ago, lithium was the only approved agent for this condition. Since that time, carbamazepine, valproate and olanzapine have received regulatory approval for the acute treatment of mania. C...

Full description

Saved in:
Bibliographic Details
Published in:Australasian psychiatry : bulletin of the Royal Australian and New Zealand College of Psychiatrists 2003-03, Vol.11 (1), p.39-53
Main Authors: Mitchell, Philip B., Malhi, Gin S., Redwood, Bernette L., Ball, Jillian
Format: Article
Language:English
Subjects:
Australasia
Bipolar affective disorder
bipolar disorder
Clinical practice
Guidelines
lithium
mania
manic‐depressive illness
mood stabilizer
Treatment methods
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The past decade has witnessed an extraordinary expansion of treatments available for bipolar disorder. Ten years ago, lithium was the only approved agent for this condition. Since that time, carbamazepine, valproate and olanzapine have received regulatory approval for the acute treatment of mania. Concurrently, randomized controlled trials of various psychological interventions have been recently reported, respecting the important psychological effects of this condition. The present summary provides recommended treatment guidelines for each phase of this condition: mania, mixed episodes, depression and long-term prophylaxis. Levels of evidence for specific treatments are provided and placed in the context of overall principles of quality clinical management.
ISSN:1039-8562
1440-1665
DOI:10.1046/j.1440-1665.2003.00520.x